Migreeni, näytönastekatsausten kirjallisuusviitteet

Kirjallisuutta

1. Abu-Arafeh I, Macleod S. Serious neurological disorders in children with chronic headache. Arch Dis Child 2005;90(9):937-40 «PMID: 16113128»PubMed
2. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group. Cephalalgia 1999;19(4):232-40 «PMID: 10376168»PubMed
3. Ahmed MA, Martinez A, Cahill D, ym. When to image neurologically normal children with headaches: development of a decision rule. Acta Paediatr 2010;99(6):940-3 «PMID: 20178515»PubMed
4. Ahonen K, Hämäläinen ML, Eerola M, ym. A randomized trial of rizatriptan in migraine attacks in children. Neurology 2006;67(7):1135-40 «PMID: 16943370»PubMed
5. Ahonen K, Hämäläinen ML, Rantala H, ym. Nasal sumatriptan is effective in treatment of migraine attacks in children: A randomized trial. Neurology 2004;62(6):883-7 «PMID: 15037686»PubMed
6. Alexiou GA, Argyropoulou MI. Neuroimaging in childhood headache: a systematic review. Pediatr Radiol 2013;43(7):777-84 «PMID: 23700196»PubMed
7. Aromaa M, Sillanpää M, Aro H. A population-based follow-up study of headache from age 7 to 22 years. J Headache Pain 2000;1:11-5
8. Aurora SK, Dodick DW, Turkel CC, ym. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia 2010;30(7):793-803 «PMID: 20647170»PubMed
9. Aurora SK, Winner P, Freeman MC, ym. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program. Headache 2011;51(9):1358-73 «PMID: 21883197»PubMed
10. Bille B. A 40-year follow-up of school children with migraine. Cephalalgia 1997;17(4):488-91; discussion 487 «PMID: 9209767»PubMed
11. Brandes JL, Kudrow D, Stark SR, ym. Sumatriptan-naproxen for acute treatment of migraine: a randomized trial. JAMA 2007;297(13):1443-54 «PMID: 17405970»PubMed
12. Brandes JL, Saper JR, Diamond M, ym. Topiramate for migraine prevention: a randomized controlled trial. JAMA 2004;291(8):965-73 «PMID: 14982912»PubMed
13. Cady RK, Schreiber CP, Porter JA, ym. A multi-center double-blind pilot comparison of onabotulinumtoxinA and topiramate for the prophylactic treatment of chronic migraine. Headache 2011;51(1):21-32 «PMID: 21070228»PubMed
14. Campinha-Bacote DL, Kendle JB, Jones C, ym. Impact of a migraine management program on improving health outcomes. Dis Manag 2005;8(6):382-91 «PMID: 16351556»PubMed
15. Dahlöf C, Björkman R. Diclofenac-K (50 and 100 mg) and placebo in the acute treatment of migraine. Cephalalgia 1993;13(2):117-23 «PMID: 8495453»PubMed
16. Derry S, Moore RA. Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 2013;2013(4):CD008040 «PMID: 23633349»PubMed
17. Derry S, Rabbie R, Moore RA. Diclofenac with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 2013;2013(4):CD008783 «PMID: 23633360»PubMed
18. Detke HC, Goadsby PJ, Wang S, ym. Galcanezumab in chronic migraine: The randomized, double-blind, placebo-controlled REGAIN study. Neurology 2018;91(24):e2211-e2221 «PMID: 30446596»PubMed
19. Dib M, Massiou H, Weber M, ym. Efficacy of oral ketoprofen in acute migraine: a double-blind randomized clinical trial. Neurology 2002;58(11):1660-5 «PMID: 12058095»PubMed
20. Diener HC, Bussone G, de Liano H, ym. Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks. Cephalalgia 2004;24(11):947-54 «PMID: 15482357»PubMed
21. Diener HC, Dodick DW, Aurora SK, ym. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia 2010;30(7):804-14 «PMID: 20647171»PubMed
22. Diener HC, Katsarava Z. Medication overuse headache. Curr Med Res Opin 2001;17 Suppl 1():s17-21 «PMID: 12463272»PubMed
23. Diener HC, Tfelt-Hansen P, Dahlöf C, ym. Topiramate in migraine prophylaxis--results from a placebo-controlled trial with propranolol as an active control. J Neurol 2004;251(8):943-50 «PMID: 15316798»PubMed
24. Dodick DW, Silberstein SD, Bigal ME, ym. Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial. JAMA 2018;319(19):1999-2008 «PMID: 29800211»PubMed
25. Dodick DW, Turkel CC, DeGryse RE, ym. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache 2010;50(6):921-36 «PMID: 20487038»PubMed
26. Goadsby PJ, Reuter U, Hallström Y, ym. A Controlled Trial of Erenumab for Episodic Migraine. N Engl J Med 2017;377(22):2123-2132 «PMID: 29171821»PubMed
27. Havanka-Kanniainen H. Treatment of acute migraine attack: ibuprofen and placebo compared. Headache 1989;29(8):507-9 «PMID: 2676908»PubMed
28. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004;24 Suppl 1():9-160 «PMID: 14979299»PubMed
29. Ho TW, Pearlman E, Lewis D, ym. Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design. Cephalalgia 2012;32(10):750-65 «PMID: 22711898»PubMed
30. Kangasniemi P, Kaaja R. Ketoprofen and ergotamine in acute migraine. J Intern Med 1992;231(5):551-4 «PMID: 1602293»PubMed
31. Karabetsos A, Karachalios G, Bourlinou P, ym. Ketoprofen versus paracetamol in the treatment of acute migraine. Headache 1997;37(1):12-4 «PMID: 9046717»PubMed
32. Katsarava Z, Fritsche G, Muessig M, ym. Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology 2001;57(9):1694-8 «PMID: 11706113»PubMed
33. Katsarava Z, Manack A, Yoon MS, ym. Chronic migraine: classification and comparisons. Cephalalgia 2011;31(5):520-9 «PMID: 21220376»PubMed
34. Kellstein DE, Lipton RB, Geetha R, ym. Evaluation of a novel solubilized formulation of ibuprofen in the treatment of migraine headache: a randomized, double-blind, placebo-controlled, dose-ranging study. Cephalalgia 2000;20(4):233-43 «PMID: 10999673»PubMed
35. Kirthi V, Derry S, Moore RA. Aspirin with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 2013;2013(4):CD008041 «PMID: 23633350»PubMed
36. Lakshmi CV, Singhi P, Malhi P, ym. Topiramate in the prophylaxis of pediatric migraine: a double-blind placebo-controlled trial. J Child Neurol 2007;22(7):829-35 «PMID: 17715274»PubMed
37. Law S, Derry S, Moore RA. Naproxen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 2013;2013(10):CD009455 «PMID: 24142263»PubMed
38. Law S, Derry S, Moore RA. Sumatriptan plus naproxen for acute migraine attacks in adults. Cochrane Database Syst Rev 2013;(10):CD008541 «PMID: 24142431»PubMed
39. Lewis D, Winner P, Saper J, ym. Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age. Pediatrics 2009;123(3):924-34 «PMID: 19255022»PubMed
40. Lewis DW, Dorbad D. The utility of neuroimaging in the evaluation of children with migraine or chronic daily headache who have normal neurological examinations. Headache 2000;40(8):629-32 «PMID: 10971658»PubMed
41. Lewis DW, Winner P, Hershey AD, ym. Efficacy of zolmitriptan nasal spray in adolescent migraine. Pediatrics 2007;120(2):390-6 «PMID: 17671066»PubMed
42. Limmroth V, Katsarava Z, Fritsche G, ym. Features of medication overuse headache following overuse of different acute headache drugs. Neurology 2002;59(7):1011-4 «PMID: 12370454»PubMed
43. Limmroth V, Kazarawa Z, Fritsche G, ym. Headache after frequent use of serotonin agonists zolmitriptan and naratriptan. Lancet 1999;353(9150):378 «PMID: 9950449»PubMed
44. Linde K, Rossnagel K. Propranolol for migraine prophylaxis. Cochrane Database Syst Rev 2004;(2):CD003225 «PMID: 15106196»PubMed
45. Linde M, Mulleners WM, Chronicle EP, ym. Topiramate for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev 2013;2013(6):CD010610 «PMID: 23797676»PubMed
46. Lipton RB, Stewart WF, Stone AM, ym. Stratified care vs step care strategies for migraine: the Disability in Strategies of Care (DISC) Study: A randomized trial. JAMA 2000;284(20):2599-605 «PMID: 11086366»PubMed
47. MacGregor EA. Contraception and headache. Headache 2013;53(2):247-76 «PMID: 23432442»PubMed
48. Massiou H, Serrurier D, Lasserre O, ym. Effectiveness of oral diclofenac in the acute treatment of common migraine attacks: a double-blind study versus placebo. Cephalalgia 1991;11(2):59-63 «PMID: 1860132»PubMed
49. Misra UK, Kalita J, Yadav RK. Rizatriptan vs. ibuprofen in migraine: a randomised placebo-controlled trial. J Headache Pain 2007;8(3):175-9 «PMID: 17563841»PubMed
50. Monastero R, Camarda C, Pipia C, ym. Prognosis of migraine headaches in adolescents: a 10-year follow-up study. Neurology 2006;67(8):1353-6 «PMID: 17060559»PubMed
51. Nestvold K. Naproxen and naproxen sodium in acute migraine attacks. Cephalalgia 1986;6 Suppl 4():81-4 «PMID: 3539361»PubMed
52. Pradalier A, Rancurel G, Dordain G, ym. Acute migraine attack therapy: comparison of naproxen sodium and an ergotamine tartrate compound. Cephalalgia 1985;5(2):107-13 «PMID: 3926322»PubMed
53. Pryse-Phillips WE, Dodick DW, Edmeads JG, ym. Guidelines for the diagnosis and management of migraine in clinical practice. Canadian Headache Society. CMAJ 1997;156(9):1273-87 «PMID: 9145054»PubMed
54. Pryse-Phillips WE, Dodick DW, Edmeads JG, ym. Guidelines for the nonpharmacologic management of migraine in clinical practice. Canadian Headache Society. CMAJ 1998;159(1):47-54 «PMID: 9679487»PubMed
55. Rabbie R, Derry S, Moore RA. Ibuprofen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 2013;2013(4):CD008039 «PMID: 23633348»PubMed
56. Ramadan NM, Schultz LL, Gilkey SJ. Migraine prophylactic drugs: proof of efficacy, utilization and cost. Cephalalgia 1997;17(2):73-80 «PMID: 9137841»PubMed
57. Rho YI, Chung HJ, Suh ES, ym. The role of neuroimaging in children and adolescents with recurrent headaches--multicenter study. Headache 2011;51(3):403-408 «PMID: 21352214»PubMed
58. Rossi LN, Vassella F. Headache in children with brain tumors. Childs Nerv Syst 1989;5(5):307-9 «PMID: 2805001»PubMed
59. Scher AI, Terwindt GM, Picavet HS, ym. Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 2005;64(4):614-20 «PMID: 15728281»PubMed
60. Schürks M, Rist PM, Bigal ME, ym. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ 2009;339():b3914 «PMID: 19861375»PubMed
61. Shamliyan TA, Choi JY, Ramakrishnan R, ym. Preventive pharmacologic treatments for episodic migraine in adults. J Gen Intern Med 2013;28(9):1225-37 «PMID: 23592242»PubMed
62. Sheikh HU, Pavlovic J, Loder E, ym. Risk of Stroke Associated With Use of Estrogen Containing Contraceptives in Women With Migraine: A Systematic Review. Headache 2018;58(1):5-21 «PMID: 29139115»PubMed
63. Silberstein SD, Dodick DW, Bigal ME, ym. Fremanezumab for the Preventive Treatment of Chronic Migraine. N Engl J Med 2017;377(22):2113-2122 «PMID: 29171818»PubMed
64. Silberstein SD, Neto W, Schmitt J, ym. Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol 2004;61(4):490-5 «PMID: 15096395»PubMed
65. Siniatchkin M, Andrasik F, Kropp P, ym. Central mechanisms of controlled-release metoprolol in migraine: a double-blind, placebo-controlled study. Cephalalgia 2007;27(9):1024-32 «PMID: 17680819»PubMed
66. Smith T, Blumenthal H, Diamond M, ym. Sumatriptan/Naproxen sodium for migraine: efficacy, health related quality of life, and satisfaction outcomes. Headache 2007;47(5):683-92 «PMID: 17501849»PubMed
67. Smith TR, Sunshine A, Stark SR, ym. Sumatriptan and naproxen sodium for the acute treatment of migraine. Headache 2005;45(8):983-91 «PMID: 16109111»PubMed
68. Stauffer VL, Dodick DW, Zhang Q, ym. Evaluation of Galcanezumab for the Prevention of Episodic Migraine: The EVOLVE-1 Randomized Clinical Trial. JAMA Neurol 2018;75(9):1080-1088 «PMID: 29813147»PubMed
69. Stovner LJ, Linde M, Gravdahl GB, ym. A comparative study of candesartan versus propranolol for migraine prophylaxis: A randomised, triple-blind, placebo-controlled, double cross-over study. Cephalalgia 2014;34(7):523-32 «PMID: 24335848»PubMed
70. Tal Y, Dunn HG, Chrichton JU. Childhood migraine--a dangerous diagnosis? Acta Paediatr Scand 1984;73(1):55-9 «PMID: 6702450»PubMed
71. Tepper S, Ashina M, Reuter U, ym. Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Neurol 2017;16(6):425-434 «PMID: 28460892»PubMed
72. Tronvik E, Stovner LJ, Helde G, ym. Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA 2003;289(1):65-9 «PMID: 12503978»PubMed
73. Ueberall MA, Wenzel D. Intranasal sumatriptan for the acute treatment of migraine in children. Neurology 1999;52(7):1507-10 «PMID: 10227648»PubMed
74. van de Ven LL, Franke CL, Koehler PJ. Prophylactic treatment of migraine with bisoprolol: a placebo-controlled study. Cephalalgia 1997;17(5):596-9 «PMID: 9251876»PubMed
75. Virtanen R, Aromaa M, Rautava P, ym. Changes in headache prevalence between pre-school and pre-pubertal ages. Cephalalgia 2002;22(3):179-85 «PMID: 12047454»PubMed
76. Virtanen R, Aromaa M, Rautava P, ym. Changing headache from preschool age to puberty. A controlled study. Cephalalgia 2007;27(4):294-303 «PMID: 17376106»PubMed
77. Visser WH, Winner P, Strohmaier K, ym. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies. Headache 2004;44(9):891-9 «PMID: 15447698»PubMed
78. Wang SJ, Fuh JL, Lu SR, ym. Outcomes and predictors of chronic daily headache in adolescents: a 2-year longitudinal study. Neurology 2007;68(8):591-6 «PMID: 17182975»PubMed
79. Wilne SH, Ferris RC, Nathwani A, ym. The presenting features of brain tumours: a review of 200 cases. Arch Dis Child 2006;91(6):502-6 «PMID: 16547083»PubMed
80. Winner P, Cady RK, Ruoff GE, ym. Twelve-month tolerability and safety of sumatriptan-naproxen sodium for the treatment of acute migraine. Mayo Clin Proc 2007;82(1):61-8 «PMID: 17285787»PubMed
81. Winner P, Lewis D, Visser WH, ym. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study. Headache 2002;42(1):49-55 «PMID: 12005275»PubMed
82. Winner P, Pearlman EM, Linder SL, ym. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial. Headache 2005;45(10):1304-12 «PMID: 16324162»PubMed
83. Winner P, Rothner AD, Saper J, ym. A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents. Pediatrics 2000;106(5):989-97 «PMID: 11061765»PubMed
84. Winner P, Rothner AD, Wooten JD, ym. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study. Headache 2006;46(2):212-22 «PMID: 16492230»PubMed
85. Wöber-Bingöl C, Wöber C, Prayer D, ym. Magnetic resonance imaging for recurrent headache in childhood and adolescence. Headache 1996;36(2):83-90 «PMID: 8742679»PubMed
86. Wörz R, Reinhardt-Benmalek B, Föh M, ym. [Prevention of migraine using bisoprolol. Results of a double-blind study versus metoprolol]. Fortschr Med 1992;110(14):268-72 «PMID: 1351025»PubMed